Merck Gives Sun Patent License In New Gimmick to Protect IP In India
This article was originally published in PharmAsia News
Executive Summary
Sun Pharmaceuticals and Merck have added to their collaboration in marketing the Januvia (sitagliptin) diabetes drug by agreeing to share the U.S. drug maker's patent for it.